25 years of Fearless Science and… EpiVax 2.0!
In case you hadn’t heard (heh), EpiVax turns 25 this year. Really. We truly never imagined this future, but we’ve had a ton of fun working with amazing scientists / friends / colleagues and collaborators all over the world for the last quarter century!
What have we learned? That human connectivity is an engine for innovation. That the best impact factor is to develop tools that get used to improve human health.
And what’s next for EpiVax 2.0? Monster Molecules? New Modalities? Gene Therapies?
More Fearless Science, say Yeah!
The official celebrations will kick off with an open house at the HQ in Rising Sun Mills, Providence, Rhode Island.
Speaking of Fearless – New GTx Immunogenicity Paper
I am totally fascinated by Gene Therapy. I am also very worried about T cell responses to AAV… not to mention the transgene. How best to measure T cell responses (which drive antibody response BTW)? How best to mitigate them? Worry no more, a comprehensive paper has just been published by Gorovitz et al. Our good friend Vibha Jawa contributed! Check it out here!
We’re coming to see you soon!
Kyoto was so last month! In keeping with tradition, we’ll be celebrating our birthday (with you!) everywhere during our 25th year! Write me here if you want to meet up at these events:
FDA Generic Drug Science and Research Public Workshop Silver Spring, MD | May 11-12
I’m presenting on Methods and Standards for Assessing the Immunogenicity Risk of Peptide APIs and Their Impurities from 1:15 PM till 2:30.
BEBPA Host Cell Protein Conference
Virtual | May 22-24 In Silico / in Vitro Methods for Immunogenicity Risk Assessment of HCP
BIO International! (Epi-Birthday in June!)
Boston MA | June 5-8